WHO ICTRP trial
A real-world clinical study of the aiding role of intestinal…
ChiCTR2200058078 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200058078 |
|---|---|
| Public title | A real-world clinical study of the aiding role of intestinal microbiome-associated metabolite in the diagnosis of early colorectal cancer and adenoma and the prediction value of recurrence after endoscopic treatment |
| Scientific title | A real-world clinical study of the aiding role of intestinal microbiome-associated metabolite in the diagnosis of early colorectal cancer and adenoma and the prediction value of recurrence after endoscopic treatment |
| Primary sponsor | First Medical Center of Chinese PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | Colorectal adenoma and early carcinoma |
| Interventions | modeling group:taking feces and blood sample ;validation group :taking blood sample |
| Registration date | Mar 29, 2022 |
| Target size | modeling group:500;validation group :1500 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: